摘要
目的:探讨脂联素(Adiponectin,ADPN)联合瘦素(Leptin,LP)在结直肠癌高危人群中的诊断价值。方法:选取2016年6月-2017年4月本院收治的结直肠癌患者50例作为A组,于同期另选取50例健康体检者作为B组,测定两组血清ADPN和LP水平,应用受试者工作特征(Receiver Operating Characteristic curve,ROC)曲线分析血清ADPN和LP对结直肠癌的诊断效能。结果:A组血清ADPN水平明显低于B组,差异有统计学意义(P<0.05);A组血清LP水平明显高于B组,差异有统计学意义(P<0.05);ROC曲线显示,两项联合对结直肠癌的敏感度和特异度最高,约登指数和曲线下面积最大。结论:联合检测脂联素联合瘦素有助于提高结直肠癌的检出率。
Objective:To discuss the diagnosis value of combining Adiponectin(ADPN) and Leptin(LP) in high risk population with colorectal cancer.Method:A total of 50 patients with colorectal cancer from June 2016 to April 2017 were selected as A group,and 50 cases of health examiner were selected as B group.The serum levels of ADPN and LP were detected.ROC curve was used to analyze the evaluate the diagnostic efficiency of ADPN combined with LP measured in the study subjects.Result:Serum levels of ADPN in A group was lower than that of B group(P〈0.05).Serum levels of LP in A group was higher than that of B group(P〈0.05).ROC curve showed:the sensitivity,specificity,Youden index and AUC of ADPN+LP was the highest.Conclusion:The combined screening of ADPN and LP can significantly improve the detection rate of colorectal cancer.
作者
彭伟如
冯奕习
梁晶晶
PENG Weiru;FENG Yixi;LIANG Jingjing(The Hospital of Traditional Chinese Medicine in Dongguan City,Dongguan 523000,Chin)
出处
《中国医学创新》
CAS
2018年第21期112-114,共3页
Medical Innovation of China
关键词
脂联素
瘦素
结直肠癌
肿瘤标志物
Adiponectin
Leptin
Colorectal cancer
Tumor marker